UCB plugs Cradle's AI protein platform into antibody discovery, from hit generation to preclinical readiness
UCB and Cradle announced a strategic collaboration that puts Cradle's AI-driven protein design platform inside selected UCB antibody discovery projects, spanning hit generation, lead optimization and preclinical readiness. UCB's digital antibody engineering program had relied on its own antibody discovery platform combined with computational science and a network of technology and research partners. Under the collaboration, experimental results feed back into program-specific models in a compounding "lab-in-the-loop" cycle used to optimize candidates across the full set of required properties.